Relay Therapeutics Inc (RLAY) support and resistance · rev $3.4M
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
This page maps Relay Therapeutics Inc (RLAY) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
RLAY currently screens at market cap $3.39B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RLAY 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RLAY quote page for the session range and the stock page for the full model.
Not investment advice.